Clinical trials
Recruiting Phase 3 Renal Insufficiency, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Novartis Pharmaceuticals | 3 |
| Amgen | 2 |
| Fundación para la Investigación del Hospital Clínico de Valencia | 2 |
| AMAG Pharmaceuticals, Inc. | 1 |
| Ain Shams University | 1 |
| Alebund Pharmaceuticals | 1 |
| Bayer | 1 |
| Eli Lilly and Company | 1 |
| Hamilton Health Sciences Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency, Chronic | 26 |
| Glomerulonephritis | 3 |
| Glomerulonephritis, IGA | 3 |
| Hyperparathyroidism, Secondary | 3 |
| Kidney Diseases | 3 |
| Stroke | 2 |
| Urologic Diseases | 2 |
| Acute Kidney Injury | 1 |
| Anemia, Iron-Deficiency | 1 |
| Atrial Fibrillation | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.